Skip to main content
logo
Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
13.91
+0.08 (0.58%)
At close: Sep 4, 2026, 4:00 PM EDT
13.45
-0.46 (-3.31%)
After-hours: Sep 4, 2026, 7:30 PM EDT

Immix Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
995276611373247
Market Cap Growth
1413.67%355.41%-55.98%331.07%-32.18%-
Enterprise Value
764261421181551
Last Close Price
13.915.232.206.922.293.56

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
4.352.944.578.492.422.61
P/TBV Ratio
4.352.944.578.382.422.61

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.010.08--0.00
Net Debt / Equity Ratio
-1.01-1.06-1.25-1.08-1.02-0.98
Net Debt / EBITDA Ratio
5.573.340.731.091.6413.04
Net Debt / FCF Ratio
5.914.031.051.531.8111.07
Quick Ratio
24.959.932.265.0210.7587.46
Current Ratio
25.1310.012.335.3211.7090.01
Return on Equity (ROE)
-34.18%-55.00%-147.33%-106.22%-52.84%-367.80%
Return on Assets (ROA)
-20.52%-29.30%-66.11%-57.92%-31.04%-9.02%
Return on Capital Employed (ROCE)
-18.20%-31.60%-159.00%-99.60%-60.30%-7.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-4.01%-10.68%-35.72%-11.22%-25.80%-51.85%
FCF Yield
-3.93%-8.95%-26.06%-8.31%-23.23%-3.38%
Buyback Yield / Dilution
-61.22%-16.55%-63.11%-24.87%-278.13%-8.82%
SEC Filings: 10-K · 10-Q